טוען...
Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
Glycosylated hemoglobin (HbA1c) has been the sole surrogate marker for assessing diabetic complications. However, consistently reported limitations of HbA1c are that it lacks detailed information on short-term glycemic control and can be easily interfered with by various clinical conditions such as...
שמור ב:
| הוצא לאור ב: | Diabetes Metab J |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Korean Diabetes Association
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7801761/ https://ncbi.nlm.nih.gov/pubmed/33389957 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4093/dmj.2020.0257 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|